Treace James T's Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed Mar 29, 2024
- Accession no.
- 0000950170-24-038822
- Filed
- Mar 29, 2024
- Trade date
- Nov 15, 2022
- Filing delay
- 500 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.01M. It was filed 500 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Treace James TCIK 0001185191 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | SSaleDisposed | −46,500 | $20.12 | −$935,580 | 1,039,941 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −1,600 | $21.18 | −$33,888 | 1,038,341 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −200 | $21.97 | −$4,394 | 1,038,141 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −1,700 | $24.02 | −$40,834 | 1,036,441 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.